16:48 , Mar 16, 2018 |  BC Week In Review  |  Financial News

Energy firm spins out biotech with $40M series A

Energy company TAE Technologies Inc. (Foothill Ranch, Calif.) spun out TAE Life Sciences (Foothill Ranch, Calif.) into a biotech subsidiary to develop a radiation therapy for cancer. The spinout raised $40 million in a series...
12:00 , Mar 12, 2018 |  BC Extra  |  Financial News

Energy firm spins out biotech with $40M series A

Energy company TAE Technologies Inc. (Foothill Ranch, Calif.) spun out TAE Life Sciences (Foothill Ranch, Calif.) into a biotech subsidiary to develop a radiation therapy for cancer. The spinout raised $40 million in a series...
19:52 , Feb 23, 2018 |  BioCentury  |  Emerging Company Profile

Cutting viruses

Armed with a suite of CRISPR nucleases and multiple guide RNAs, Excision BioTherapeutics Inc. is using gene editing to cut out integrated latent viruses from host genomes. The newco is starting with HIV, but has...
05:08 , Nov 17, 2017 |  BC Week In Review  |  Financial News

Venture roundup: ImmusanT, Locus

On Nov. 14, autoimmune company ImmusanT Inc. (Cambridge, Mass.) and antimicrobial play Locus Biosciences Inc. (Research Triangle Park, N.C.) announced venture financings totaling nearly $60 million. ImmusanT raised $40 million in a series C round...
00:11 , Nov 15, 2017 |  BC Extra  |  Financial News

Venture Roundup: ImmusanT, Locus

On Tuesday, autoimmune company ImmusanT Inc. (Cambridge, Mass.) and antimicrobial play Locus Biosciences Inc. (Research Triangle Park, N.C.) announced venture financings totaling nearly $60 million. ImmusanT raised $40 million in a series C round led...
20:42 , Sep 8, 2017 |  BC Week In Review  |  Financial News

Excision raises $10M seed round

On Sept. 6, gene editing company Excision BioTherapeutics Inc. (Philadelphia, Pa.) raised $10 million in a seed round led by Artis Ventures. Other undisclosed investors also participated. Excision is developing therapeutics to treat viral infectious...
23:21 , Sep 6, 2017 |  BC Extra  |  Financial News

Excision raises $10M seed round

Gene editing company Excision BioTherapeutics Inc. (Philadelphia, Pa.) raised $10 million in a seed round led by Artis Ventures. Other undisclosed investors also participated. Excision is developing therapeutics to treat viral infectious diseases by utilizing...
07:00 , Sep 12, 2016 |  BC Week In Review  |  Financial News

IDbyDNA completes venture financing

IDbyDNA Inc. , San Francisco, Calif.   Business: Diagnostic   Date completed: 2016-09-08   Type: Venture financing   Raised: $9 million   Investors: Artis Ventures; ARUP Laboratories; private investors  ...
07:00 , Sep 8, 2016 |  BC Extra  |  Financial News

IDbyDNA raises $9M for diagnostic software

Infectious disease diagnostics developer IDbyDNA Inc. (Sunnyvale, Calif.) raised $9 million in a series A round led by Artis Ventures. Arup Laboratories (Salt Lake City, Utah) and other private investors also participated. IDbyDNA's Taxonomer metagenomics...
07:00 , Jun 13, 2016 |  BC Week In Review  |  Financial News

Omicia completes venture financing

Omicia Inc. , Oakland, Calif.   Business: Bioinformatics   Date completed: 2016-06-08   Type: Venture financing   Raised: $23 million   Investors: UPMC Enterprises; Roche Venture Fund; LDV Partners; Ping An Ventures; Artis Ventures; Acadia...